LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

13th October 2026

Lonza Launches Enhanced DNA-to-IND Offering, Enabling IND Readiness in as Little as Six Months for More Complex Biologics

12th October 2026

Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors

12th October 2026

Inizio Evoke Adds Leadership Bench to Accelerate Client Innovation and Growth

9th October 2026

Lonza and Onava Collaborate to Accelerate AI-Native Biologics Discovery with GS Ori-Go Vectors®

9th October 2026

Three new commercial appointments for Symbiosis to drive international growth

9th October 2026

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

8th October 2026

ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

6th October 2026

CPHI Pharma Awards 2026 winners announced in Milan

6th October 2026

CPHI targets Spain’s €38bn pharma market with new Barcelona event

6th October 2026

CPHI Frankfurt expands for 2027 with three new dedicated exhibitor zones

6th October 2026

Bespak announces collaboration with Shin Nippon Biomedical Laboratories to expand global access to FDA-approved nasal dry powder device

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations